India’s first Omicron-specific mRNA booster vaccine:GEMCOVAC-OM

India’s Department of Biotechnology (DBT) has announced the approval of Pune-based Gennova Biopharmaceuticals for emergency use authorization from the Drugs Controller General of India (DCGI) for its mRNA COVID-19 booster vaccine, GEMCOVAC-OM.
The vaccine, designed specifically against the Omicron variant of SARS-CoV2, has shown promising results in phase 3 clinical trials, indicating its potential to prevent future waves of the pandemic.